Immunological considerations for developing antibody therapeutics for Influenza A.
about
Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applicationsProgress towards understanding the pathogenesis of dengue hemorrhagic fever.Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy.
P2860
Immunological considerations for developing antibody therapeutics for Influenza A.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immunological considerations for developing antibody therapeutics for Influenza A.
@en
Immunological considerations for developing antibody therapeutics for Influenza A.
@nl
type
label
Immunological considerations for developing antibody therapeutics for Influenza A.
@en
Immunological considerations for developing antibody therapeutics for Influenza A.
@nl
prefLabel
Immunological considerations for developing antibody therapeutics for Influenza A.
@en
Immunological considerations for developing antibody therapeutics for Influenza A.
@nl
P2860
P1476
Immunological considerations for developing antibody therapeutics for Influenza A.
@en
P2093
Kristine M Swiderek
Po-Ying Chan-Hui
P2860
P304
P356
10.1080/21645515.2015.1079676
P577
2015-09-01T00:00:00Z